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Early detection and identification of mycobacteria in 
clinical specimens is of great importance for the control 
of infection and timely choice of drug therapy. 
Although direct detection of mycobacteria by poly- 
merase chain reaction (PCR)-based methods is able to 
provide information within 24-48 h [1-5], conven- 
tional culture remains the most reliable diagnostic tool 
and permits subsequent identification of the isolated 
mycobacteria and susceptibility testing. It is therefore 
important to develop a system or medium for the 
culture of mycobacteria that is sensitive and provides 
specific identification by molecular methods in the 
shortest time possible. 
A preliminary study evaluating a new non- 
radiometric cultural method for the detection of 
mycobacteria has been reported [6].  This test, MB 
Redox (Biotest, Dreiech, Germany), is a manual 
colorimetric cultural system which includes a 
modified serum-supplemented Kirchner medium 
containing the antibiotic mixture PACT (polymixin B, 
amphotericin B, carbenicillin and trimethoprim) and 
specific growth additives. The purpose of this 
investigation was to evaluate the sensitivity and 
specificity of a coupled cultural-biomolecular method 
(MB Redox-multiplex PCR) for rapid isolation of 
mycobacteria and identification of the genus 
Mycobacierium, and the individual species M. 
tuberculosis, M.  avium and M.  intracellulare. The present 
study describes initial trial experiments with the 
method in which multiplex PCR was performed on 
cultures growing in the MB Redox system. The time 
taken to obtain a positive result was then compared 
with the time taken for culture alone. 
The mycobacterial strains used in this work were: 
M. tuberculosis ATCC 27294 and four clinical isolates of 
M. tuberculosis; M. avium ATCC 25291 and four clinical 
isolates of M. avium; M.  intracellulare ATCC 13950 and 
two clinical isolates of M.  intracellulare; and M. kansasii 
ATCC 12478 and two clinical isolates of M. kansasii. 
Clinical isolates were from respiratory specimens ob- 
tained from AIDS patients by culture on Lowenstein- 
Jensen slants (Difco, Detroit, MI, USA) and were 
identified with probes of the AccuProbe series (Gen- 
Probe, San Diego, CA, USA) after processing according 
to standard methods [7]. 
After culture for 20 days, colonies of each strain 
were transferred to a tube containing 10 mL of 
Middlebrook 7H9 broth (Difco) and 20 glass beads. 
Each tube was vortexed and then allowed to settle for 
30 min to remove the large clumps [8]. Each suspension 
was adjusted to a McFarland 1.0 standard and 1 mL 
aliquots were stored at -80°C until used. Each stock 
was diluted 10-fold from lo-‘ to in both 
Middlebrook 7H9 broth and in MB Redox medium. 
A 100-pL sample of each dilution obtained from 7H9 
broth was spread in quadruplicate on Middlebrook 
7Hl l  agar plates (Difco) for CFU counts and was also 
inoculated in duplicate into MB Redox tubes 
containing 4 mL of growth medium. The first tube was 
used for macroscopic evaluation of mycobacterial 
growth and the second tube was used for PCR. Cultures 
were incubated at 37OC in a 5% COz atmosphere. 
In each experiment, CFU counts and MB Redox 
cultures were performed simultaneously. Mycobacterial 
DNA was extracted from 100 pL of each starting stock 
dilution in both 7H9 and MB Redox medium, and also 
from 1 mL of each MB Redox culture on days 0, 3, 6 
and 12 after inoculation. To test the multiplex PCR 
method when more than one target species was present, 
DNA samples were also extracted from mixtures 
obtained from cultures of all the mycobacterial species 
used in this study. Samples were centrifuged at 12 600 g 
for 10 min and the pellets resuspended in 50 pL of lysis 
buffer (1% Triton X-100, 10 mM Tris (pH 8.0), 1 mh4 
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EDTA); this was followed by heating at 100°C for 
30 min [9]. The heat-treated samples were then 
centrifuged at 12 600 g for 2 min and the supernatants 
stored at -20°C until required. Four clinical isolates of 
Staphylococcus aureus, Streptococcus pneumoniae, Nocardia 
spp. and Corynebacterium spp. were used to assess the 
specificity of the multiplex PCR. 
Multiplex PCR was performed in a single tube by 
a previously described method with primers that 
detected the 16s rRNA gene of members of the genus 
Mycobacterium (MYCGEN-F and MYCGEN-R, 1030 
bp), and primers which recognized M. avium 
(MYCAV-R and MYCGEN-E 180 bp), M.  intra- 
cellulare (MYCINT-F and MYCGEN-R, 850 bp) and 
the MPB70 gene of M .  tuberculosis (TB1-F and 
TB1-R, 372 bp) [lo]. Fifty-microliter PCR mixtures 
contained, at a final concentration, X l  PCR buffer 
(50 mM NaC1, 10 mM Tris-HC1 (PH 8.3), 2.0 mM 
MgClZ), 0.2 mM of each dNTP, primers (86 ng 
each of MYCGEN-F and MYCGEN-R, 80 ng of 
MYCINT-F, 40 ng of MYCAV-R, and 30 ng each of 
TBZ-F and TB1-R), 1.5 U of Tuq polymerase (Perkin- 
Elmer, Cetus Emeryville, California, USA) and 10 pL 
of mycobacterial DNA. Cycling conditions with the 
GeneArnp PCR System 9600 (Perkin-Elmer) were: 
one cycle of 94°C for 10 min, 62°C for 60 s and 72OC 
for 60 s; 40 cycles of 94°C for 30 s, 62°C for 45 s and 
72OC for 45 s; and one cycle of 94°C for 30 s, 62OC 
for 60 s and 72OC for 10 min. To avoid false-positive 
results, culture, DNA extraction, PCRs and amplifi- 
cation analysis were performed in separate laboratories 
and biosafety hoods. PCR products (5 pL) were 
separated on 3% agarose gels by electrophoresis and 
then stained with ethidium bromide. 
For each culture, a correlation was observed 
between the number of CFUs inoculated in each tube 
and the time of macroscopic positivity (Table 1). When 
the specificity of the multiplex PCR for the identifi- 
cation of members of the genus Mycobacterium and 
differentiation among M .  tuberculosir, M.  avium, and M.  
intracellulare was evaluated, it was found that all myco- 
bacterial strains tested were positive by PCR for the 
1030-bp fragment with primers MYCGEN-F and 
MYCGEN-R, whereas all non-mycobacterial isolates 
were negative. Reference strains and clinical isolates 
that had been identified previously by DNA probe 
methods were always confirmed by multiplex PCR. 
Strains of M. kansasii were positive only for the 1030- 
bp fragment characteristic of the genus Mycobacterium. 
When mixtures obtained from all mycobacterial species 
were tested, positive PCR signals were obtained 
simultaneously for the 1030-bp fragment (genus 
Table 1 Time required for macroscopic detection of different initial mycobacterial stock ddutions by MB Redox cultures 
Time required (days) for detection of different initial inocula (CFU) 
~ 
60 000 6000 600 60 6 
Strains (105 to 2x104)” (104 to 2x103)a (103 to 200)” (100-20)“ (10-2)‘ 
M tuberculosis 
ATCC 27294 6 6 6 12 14 
Clinical isolate 1 7 8 12 14 14 
Clinical isolate 2 6 6 8 12 15 
Clinical isolate 3 6 8 8 12 14 
Clinical isolate 4 7 7 10 12 14 
M.  avium 
ATCC 25291 4 
Clinical isolate 1 4 
Clinical isolate 2 3 
Clinical isolate 3 2 
Clinical isolate 4 4 
M. intracellulare 
ATCC 13950 3 
Clinical isolate 1 3 
Clinical isolate 2 3 
M .  kansasii 
ATCC 12478 3 
Clinical isolate 1 3 
Clinical isolate 2 3 
6 
7 
7 
7 
6 
6 
7 7 10 
7 7 8 
6 6 8 
6 6 9 
6 8 8 
8 12 12 
7 9 9 
8 8 9 
8 10 12 
8 10 12 
7 10 10 
’Range of values 
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1 J  ' ' ' 
0 2 4 6 8 10 12 14 16 0 2 4 6 8 10 12 
Time (days) required for detection Time (days) required for detection 
0 2 4 6 8 1 0 1 2  
Time (days) required for detection 
0 2 4 6 8 1 0 1 2  
Time (days) required for detection 
Figure 1 Comparison of time required for detection of stock dilutions of (A) M. tuberculosis, (B) M .  aoium, 
(C) M. intracellulare and (D) M. kansasii. Values shown are means obtained with each stock dilution ( +, positive by culture; 
B, positive by multiplex PCR). 
Mycobacterium), the 180-bp fragment (M. avium), the 
850-bp fragment (M. intracellulare) and the 372-bp 
fiagment (M.  tuberculosis). 
The sensitivity of the multiplex PCR was evalu- 
ated directly with samples of each starting stock 
dilution inoculated into 7H9 and MF3 Redox medium. 
On days 0, 3, 6 and 12 after inoculation, 1 mL was 
taken from each culture and subjected to DNA 
extraction and amplification. Only cultures containing 
26 X lo3 CFU could be detected by multiplex PCR on 
day 0. The same cultures became macroscopically 
positive 3 days later (Figure 1). For the cultures of M .  
avium, M.  intracellulare and M. kansasii with an initial 
inoculum of 6 to 6x10' CFU, positive results were 
obtained by multiplex PCR 3-6 days after inoculation. 
AU cultures became macroscopically positive 2-5 days 
later, With M .  tuberculosis, an initial inoculum of 6X lo2 
CFU could be detected on day 6, while six CFUs were 
detected on day 12 after inoculation (Figure 1A). AU 
cultures were macroscopically positive 2-3 days later. 
The results demonstrate that, for all mycobacterial 
strains tested, multiplex PCR can not only reduce the 
time of detection by 2-6 days, but also allows 
differential identification of M. tuberculosis, M.  avium, 
and M. intracellulare. The results showed that a single 
PCR reaction can be performed on day 12 to detect an 
initial inoculum of six CFUs. The advantages of MB 
Redox cultures include reduced labor costs, ease of 
handling and the reduced time required for myco- 
bacterial detection. No PCR inhibitors are present in 
the medium and it is possible to carry out multiplex 
PCR directly on heavy growth. Multiplex PCR is 
simple, rapid, specific and cost-saving compared with 
expensive DNA probes, subcloning procedures and 
biochemical tests. However, non-viable and non- 
cultivable mycobacteria will be missed when PCR is 
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dependent on culture, although this point requires 
evaluation with a larger number of clinical specimens. 
Such large-scale studies on clinical specimens will also 
be required before this procedure might be of interest 
for the diagnosis of mycobacterial infection. In 
particular, decontamination of clinical specimens and 
contamination of cultures by non-mycobacterial strains 
might influence the sensitivity and specificity of the 
method and require careful evaluation. 
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Capnocytophaga canimorsus is a Gram-negative, fusi- 
form, micro-aerophilic rod. The organism is part of 
the normal oral flora in cats and dogs [l]. The 
estimated incidence of septicemia in humans is 0.5 
cases per million inhabitants per year [2]. The disease 
especially affects asplenic or alcoholic individuals and 
patients using steroids. Fifty per cent of the patients 
had been bitten by a dog in the week before admission 
C. canimorsus has been identified as a cause of 
tricuspid valve endocarditis in patients with risk factors 
PI. 
for infection with C .  canimorsus or with cardiac 
abnormalities. We report a case of rapidly progressive 
right ventricular failure due to right-sided endocarditis 
caused by C. canirnorsus in an immunocompetent 
woman without structural cardiac defects. 
A 69-year-old woman with a history of chronic 
obstructive pulmonary disease (COPD) developed 
progressive edema in both legs in 2 weeks, without 
progressive dyspnea or orthopnea. She had no history 
of cardiac disease. O n  examination she was slightly 
dyspneic, with a blood pressure of 110/85 mmHg, a 
